Organigram Global (NASDAQ:OGI) versus Lifeward (NASDAQ:LFWD) Critical Contrast

Lifeward (NASDAQ:LFWD – Get Free Report) and Organigram Global (NASDAQ:OGI – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.

Analyst Recommendations

This is a summary of current recommendations and price targets for Lifeward and Organigram Global, as provided by MarketBeat.

Lifeward currently has a consensus price target of $10.00, indicating a potential upside of 37.55%. Given Lifeward’s higher possible upside, research analysts clearly believe Lifeward is more favorable than Organigram Global.

Profitability

This table compares Lifeward and Organigram Global’s net margins, return on equity and return on assets.

Risk & Volatility

Lifeward has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500.

Insider & Institutional Ownership

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 1.5% of Lifeward shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Lifeward and Organigram Global”s gross revenue, earnings per share and valuation.

Organigram Global has higher revenue and earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Summary

Organigram Global beats Lifeward on 12 of the 14 factors compared between the two stocks.

About Lifeward

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

About Organigram Global

(Get Free Report)

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.